home / stock / dxcm / dxcm news


DXCM News and Press, DexCom Inc. From 02/08/24

Stock Information

Company Name: DexCom Inc.
Stock Symbol: DXCM
Market: NASDAQ
Website: dexcom.com

Menu

DXCM DXCM Quote DXCM Short DXCM News DXCM Articles DXCM Message Board
Get DXCM Alerts

News, Short Squeeze, Breakout and More Instantly...

DXCM - DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript

2024-02-08 21:00:26 ET DexCom, Inc. (DXCM) Q4 2023 Earnings Conference Call February 8, 2024 4:30 PM ET Company Participants Sean Christensen - Head of Investor Relations Kevin Sayer - Chairman, President, and Chief Executive Officer Jereme Sylvain - Chief Financ...

DXCM - DexCom (DXCM) Q4 2023 Earnings Call Transcript

2024-02-08 19:45:21 ET Image source: The Motley Fool. DexCom (NASDAQ: DXCM) Q4 2023 Earnings Call Feb 08, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: DexCom (DXCM) Q4 2023 Earnings Call Transcript

DXCM - DexCom beats top-line and bottom-line estimates; reaffirms FY24 outlook

2024-02-08 16:14:23 ET More on DexCom DexCom: Stelo Stellar Outlook Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy Seeking Alpha’s Quant Rating on DexCom Read the full article on Seeking Alpha For further detail...

DXCM - Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue grew 27% versus the same quarter of the prior year to $1.03 billion on a reported basis and 26% on ...

DXCM - Prediction: 2 Stocks That Could Trounce the Market

2024-02-08 10:00:00 ET Every investor wants to beat the market, but doing so is notoriously difficult. That's why many settle for matching the performance of some prominent index by buying the appropriate exchange-traded funds (ETFs). However, it's possible to crush the market by invest...

DXCM - Expected US Company Earnings on Thursday, February 8th, 2024

Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...

DXCM - DexCom Q4 2023 Earnings Preview

2024-02-07 17:20:17 ET More on DexCom DexCom: Stelo Stellar Outlook Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy Baird bullish on medtech in 2024, but sees weakness in dental market Dexcom stock rises 4% on preliminary Q4 re...

DXCM - Stocks with the highest upside to BofA's price objectives

2024-02-07 14:15:08 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...

DXCM - Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People

Dexcom ONE+ is available today in Spain, Belgium, and Poland with the Netherlands launching next week, and additional countries to be announced in the coming months. New system continues to ensure more people can gain access to accurate 1 , easy-to-use †2 , real-time CGM ...

DXCM - Tracking Baillie Gifford's 13F Portfolio - Q4 2023 Update

2024-01-28 11:52:19 ET Summary Baillie Gifford's 13F portfolio value increased from ~$110B to ~$126B this quarter. The top three holdings are MercadoLibre, NVIDIA, and Amazon.com, accounting for ~17% of the portfolio. Baillie Gifford increased stakes in PDD Holdings, Shopify, ...

Previous 10 Next 10